A-232

From WikiMD.com Medical Encyclopedia


Overview[edit | edit source]

Chemical structure of A-232

A-232 is a chemical compound that belongs to the class of nerve agents known as Novichok agents. These agents were developed in the Soviet Union during the late stages of the Cold War and are known for their high toxicity and potential use in chemical warfare. A-232 is part of a series of compounds designed to be more potent than traditional nerve agents like sarin and VX.

Chemical Properties[edit | edit source]

A-232 is an organophosphate compound, which means it contains phosphorus bonded to carbon and oxygen atoms. The chemical structure of A-232 is designed to inhibit the enzyme acetylcholinesterase, leading to an accumulation of the neurotransmitter acetylcholine in the synaptic cleft. This results in continuous stimulation of muscles, glands, and central nervous system structures, causing the symptoms associated with nerve agent poisoning.

Mechanism of Action[edit | edit source]

The primary mechanism of action of A-232, like other nerve agents, is the inhibition of acetylcholinesterase. This enzyme is responsible for breaking down acetylcholine in the synaptic cleft. When acetylcholinesterase is inhibited, acetylcholine accumulates, leading to overstimulation of muscarinic and nicotinic receptors. This overstimulation causes a range of symptoms, including muscle twitching, respiratory distress, and potentially death due to respiratory failure.

Symptoms of Exposure[edit | edit source]

Exposure to A-232 can result in a variety of symptoms, depending on the dose and route of exposure. Common symptoms include:

  • Miosis (constriction of the pupils)
  • Excessive salivation
  • Sweating
  • Muscle twitching
  • Convulsions
  • Respiratory distress
  • Loss of consciousness

Treatment[edit | edit source]

The treatment for exposure to A-232 involves the use of antidotes such as atropine and pralidoxime. Atropine works by blocking the muscarinic effects of acetylcholine, while pralidoxime reactivates acetylcholinesterase by removing the phosphate group attached by the nerve agent. Supportive care, including mechanical ventilation, may also be necessary in severe cases.

Development and History[edit | edit source]

The development of Novichok agents, including A-232, was part of a secret Soviet program aimed at creating more effective chemical weapons. These agents were designed to be undetectable by standard NATO chemical detection equipment and to circumvent the Chemical Weapons Convention. The existence of Novichok agents was revealed by defectors in the 1990s, leading to increased international awareness and concern.

Related pages[edit | edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD